Cerebrovascular Disease in HIV-Infected Patients

  • A. Moulignier


Neurological complications of HIV-1 infection, due either to the immunosuppression (opportunistic infections and neoplasms) or the neurotropism of the virus, are common and add considerably to the morbidity and mortality of the infection. Their frequency varies according to the stage of the disease. They have been reported to represent 10–15% of symptomatic primo-infection, and are the first manifestation of AIDS in 10–20% of symptomatic HIV-1 infection cases. Their prevalence in clinical studies has been estimated to range from 40 to 70%, and a prospective study revealed that neurological findings were present in 90% of AIDS patients examined by a neurologist


Human Immunodeficiency Virus Cerebrovascular Disease Cerebral Venous Thrombosis Mycotic Aneurysm Human Immunodeficiency Virus Infec 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Malouf R, Jacquette G, Dobkin J, Brust JCM (1990) Neurologic disease in human immunodeficiency virus-infected drug abusers. Arch Neurol 47:1002–1007PubMedGoogle Scholar
  2. 2.
    Moulignier A (2006) HIV and the central nervous system. Rev Neurol (Paris) 162:22–42Google Scholar
  3. 3.
    Moulignier A, Moulonguet A (2007) Complications neurologiques. In: Katalama C, Girard P-M, Pialoux G (eds) VIH 2007. Doin, Reuil Malmaison, pp 97–133Google Scholar
  4. 4.
    Sacktor N (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 8(Suppl 2):115–121PubMedGoogle Scholar
  5. 5.
    Gray F, Bazille C, Addle-Biassette H et al (2005) Central nervous system immune reconstitution disease in AIDS patients receiving highly active antiretroviral treatment. J Neurovirol 11(Suppl 3):16–22PubMedGoogle Scholar
  6. 6.
    Scaravilli F, Bazille C, Gray F (2007). Neuropathologic contributions to understanding AIDS and the central nervous system. Brain Pathol 17:197–208PubMedGoogle Scholar
  7. 7.
    Jellinger KA, Setinek U, Drlicek M et al (2000) Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathol 100:213–220PubMedGoogle Scholar
  8. 8.
    Snider WD, Simpson DM, Nielsen S et al (1983) Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14:403–418PubMedGoogle Scholar
  9. 9.
    Rabinstein AA (2003) Stroke in HIV-infected patients: a clinical perspective. Cerebrovasc Dis 15:37–44PubMedGoogle Scholar
  10. 10.
    Kamin DS, Grinspoon SK (2005) Cardiovascular disease in HIV-positive patients. AIDS 19:641–652PubMedGoogle Scholar
  11. 11.
    d’Arminio Monforte A, Bongiovanni M (2005) Cerebrovascular disease in highly active antiretroviral therapy-treated individuals: incidence and risk factors. J Neurovirol 11(Suppl 3):34–47Google Scholar
  12. 12.
    Moulignier A (2007) Dementia due to HIV disease and aging. Psychol Neuropsychiatr Vieil 5:1–15Google Scholar
  13. 13.
    Pinto AN (1996) AIDS and cerebrovascular disease. Stroke 27:538–543PubMedGoogle Scholar
  14. 14.
    Ortiz G, Koch S, Romano JG et al (2007) Mechanisms of ischemic stroke in HIV-infected patients. Neurology 68:1257–1261PubMedGoogle Scholar
  15. 15.
    Tipping B, de Villiers L, Wainwright H et al (2007) Stroke in patients with human immunodeficiency virus infection. J Neurol Neurosurg Psychiatry 78:1320–1324PubMedGoogle Scholar
  16. 16.
    Cole JW, Pinto AN, Hebel JR et al (2004) Acquired immunodeficiency syndrome and the risk of stroke. Stroke 35:51–56PubMedGoogle Scholar
  17. 17.
    Levy RM, Bredesen DE (1988) Central nervous system dysfunction in acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 1:41–64PubMedGoogle Scholar
  18. 18.
    Evers S, Nabavi D, Rahmann A et al (2003) Ischaemic cerebrovascular events in HIV infection: a cohort study. Cerebrovasc Dis 15:199–205PubMedGoogle Scholar
  19. 19.
    Hoffmann M, Berger JR, Nath A, Rayens (2000) Cerebrovascular disease in young, HIV-infected black Africans in the KwaZulu natal province of South Africa. J Neurovirol 6:229–236PubMedGoogle Scholar
  20. 20.
    d’Arminio A, Sabin CA, Phillips AN et al; Writing Committee of the DAD Study Group (2004) Cardioand cerebrovascular events in HIV-infected persons. AIDS 18:1811–1817PubMedGoogle Scholar
  21. 21.
    Bozzette SA, Ake CF, Tam HK et al (2003) Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 348:702–710PubMedGoogle Scholar
  22. 22.
    Holmberg SD, Moorman AC, Williamson JM et al (2002) Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 306:1747–1748Google Scholar
  23. 23.
    Levy RM, Bredesen DE, Rosenblum ML (1985) Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 62:475–495PubMedGoogle Scholar
  24. 24.
    Koppel BS, Wormser GP, Tuchman AJ et al (1985) Central nervous system involvement in patients with acquired immunodeficiency syndrome (AIDS). Acta Neurol Scand 71:337–353PubMedCrossRefGoogle Scholar
  25. 25.
    Berger JR, Moskowitz L, Fischl M, Kelley RE (1987) Neurological disease as the presenting manifestation of acquired immunodeficiency syndrome. South Med J 80:683–686PubMedGoogle Scholar
  26. 26.
    McArthur JC (1987) Neurological manifestations of AIDS. Medicine 66:407–437PubMedGoogle Scholar
  27. 27.
    Engstrom JW, Lowenstein DH, Bredesen DE (1989) Cerebral infarctions and transient neurologic deficits associated with acquired immunodeficiency syndrome. Am J Med 86:528–532PubMedGoogle Scholar
  28. 28.
    Moskowitz LB, Hensley GT, Chan JC et al (1984) The neuropathology of acquired immunodeficiency syndrome. Arch Pathol Lab Med 108:867–872PubMedGoogle Scholar
  29. 29.
    Anders KH, Guerra WF, Tomiyasu U, Vinters HV (1986) The neuropathology of AIDS: UCLA experience and review. Am J Pathol 124:537–558PubMedGoogle Scholar
  30. 30.
    Rosemberg S, Lopes MBS, Tsanadis AM (1986) Neuropathology of acquired immunodeficiency syndrome: analysis of 22 Brazilian cases. J Neurol Sci 76:187–198PubMedGoogle Scholar
  31. 31.
    Mizusawa H, Hirano A, Llena SF, Shintaku M (1988) Cerebrovascular lesions of AIDS. Acta Neuropathol 76:451–457PubMedGoogle Scholar
  32. 32.
    Esiri MM, Scaravilli F, Millard PR, Harcourt-Webster JN (1989) Neuropathology of HIV infection in hemophiliacs: comparative necropsy study. Br Med J 299:1312–1315Google Scholar
  33. 33.
    Berger JR, Harris JO, Gragorios J, Norenberg M (1990) Cerebrovascular disease in AIDS: a case control study. AIDS 4:239–244PubMedGoogle Scholar
  34. 34.
    Kieburtz KD, Eskin TA, Ketonen L, Tuite MJ (1993) Opportunistic cerebral vasculopathy and stroke in patients with AIDS. Arch Neurol 50:430–432PubMedGoogle Scholar
  35. 35.
    Connor MD, Lammie GA, Bell JE et al (2000) Cerebral infarction in adult AIDS patients: observations from the Edinburgh HIV Autopsy Cohort. Stroke 31:2117–2126PubMedGoogle Scholar
  36. 36.
    Gillams AR, Allen E, Hrieb K et al (1997) Cerebral infarction in patients with AIDS. Am J Neuroradiol 18:1581–1585PubMedGoogle Scholar
  37. 37.
    Grindal AB, Cohen RJ, Saul RF et al (1978) Cerebral infarction in young adults. Stroke 9:39–42PubMedGoogle Scholar
  38. 38.
    Kristensen B, Malm J, Carlberg B et al (1997) Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke 28:1702–1709PubMedGoogle Scholar
  39. 39.
    Berger K, Schulte H, Stögbauer F, Assmann G (1998) Incidence and risk factors for stroke in an occupational cohort: the PROCAM study. Stroke 29:1562–1566PubMedGoogle Scholar
  40. 40.
    Qureshi AI, Janssen RS, Karon JM et al (1997) Human immunodeficiency virus infection and stroke in young patients. Arch Neurol 54:1150–1153PubMedGoogle Scholar
  41. 41.
    Bajwa ZH, Libman R, Lipton RB et al (1991) Cerebrovascular disease in patients with HIV. Neurology 41(Suppl 1):S295Google Scholar
  42. 42.
    Baily GG, Mandal BK (1995) Recurrent transient neurological deficits in advanced HIV infection. AIDS 9:709–712PubMedGoogle Scholar
  43. 43.
    Brew BJ, Miller J (1996) Human immunodeficiency virus type 1-related transient neurological deficits. Am J Med 10:257–261Google Scholar
  44. 44.
    Rinaldi R, Manfredi R, Azzimondi G et al (1997) Recurrent ‘migrainelike’ episodes in patients with HIV disease. Headache 37:443–448PubMedGoogle Scholar
  45. 45.
    Klein JL, Price DA, Fisher M, Coker RJ (1996) Cytomegalovirus infection: a possible cause of recurrent transient neurological dysfunction in advanced HIV infection. AIDS 10:345–346PubMedGoogle Scholar
  46. 46.
    Card T, Wathen CG, Luzzi GA (1998) Primary HIV-1 infection presenting with transient neurological deficit. J Neurol Neurosurg Psychiatry 6:281–282Google Scholar
  47. 47.
    Atalaia A, Ferro J, Antunes F (1992) Stroke in an HIV-infected patient. J Neurol 239:356–357PubMedGoogle Scholar
  48. 48.
    Bradley TP, Vas G (1997) HIV type-1-related transient neurologic deficits. Am J Med 103:250PubMedGoogle Scholar
  49. 49.
    Zunker P, Nabavi DG, Allardt A et al (1996) HIVassociated stroke: report of two unusual cases. Stroke 27:1694–1696PubMedGoogle Scholar
  50. 50.
    Vittecoq D, Escaut L, Monsuez JJ (1998) Vascular complications associated with use of HIV protease inhibitors. Lancet 351:1959PubMedGoogle Scholar
  51. 51.
    Casado-Naranjo I, Toledo-Santos JA, Antolin-Rodriguez MA (1992) Ischemic stroke as the sole manifestation of HIV infection. Stroke 23:117–118PubMedGoogle Scholar
  52. 52.
    Mochan A, Modi M, Modi G (2003) Stroke in black South African HIV-positive patients: a prospective analysis. Stroke 34:10–15PubMedGoogle Scholar
  53. 53.
    Roldan EO, Moskowitz L, Hensley GT (1987) Pathology of the heart in acquired immunodeficiency syndrome. Arch Pathol Lab Med 111:943–946PubMedGoogle Scholar
  54. 54.
    Lai WW, Colan SD, Easley KA et al (2001) Dilation of the aortic root in children infected with human immunodeficiency virus type 1: The Prospective P2C2 HIV Multicenter Study. Am Heart J 141:661–670PubMedGoogle Scholar
  55. 55.
    Anders KH, Latta H, Chang BS et al (1989) Lymphomatoid granulomatosis and malignant lymphoma of the central nervous system in the acquired immunodeficiency syndrome. Hum Pathol 20:326–334PubMedGoogle Scholar
  56. 56.
    Geier SA, Perro C, Klauss V et al (1993) HIV-related ocular microangiopathic syndrome and cognitive functioning. J Acquir Immune Defic Syndr 6:252–258PubMedGoogle Scholar
  57. 57.
    Scaravilli F, Daniel SE, Harcourt-Webster N, Guiloff RJ (1989) Chronic basal meningitis and vasculitis in acquired immunodeficiency syndrome: a possible role for human immunodeficiency virus. Arch Pathol Lab Med 113:192–195PubMedGoogle Scholar
  58. 58.
    Yankner BA, Skolnik PR, Shoukimas GM et al (1986) Cerebral granulomatous angiitis associated with isolation of human T-lymphotropic virus type III from the central nervous system. Ann Neurol 20:362–364PubMedGoogle Scholar
  59. 59.
    Nogueras C, Sala M, Sasal M et al (2002) Recurrent stroke as a manifestation of primary angiitis of the central nervous system in a patient infected with human immunodeficiency virus. Arch Neurol 59:468–473PubMedGoogle Scholar
  60. 60.
    Evidente V, Yagnik P (1995) Stroke and stroke-like syndromes in the acquired immunodeficiency syndrome. Neurology 45(Suppl 4):A444Google Scholar
  61. 61.
    Brannagan TH (1997) Retroviral-associated vasculitis of the nervous system. Neurol Clin 15:927–944PubMedGoogle Scholar
  62. 62.
    van der Ven AJ, van Oostenbrugge RJ, Kubat B, Tervaert JW (2002) Cerebral vasculitis after initiation of antiretroviral therapy. AIDS 16:2362–2364PubMedGoogle Scholar
  63. 63.
    Dehais C, Moulignier A, Deschamps R et al (2004) Immune reconstitution vasculitis in an HIV-infected patient (abstract). Program of the Journées de Neurologie de Langue Française, StrasbourgGoogle Scholar
  64. 64.
    Moulignier A, Laloum L, Chauveau E et al (2003) HIV-1-related ischaemic trochlear nerve palsy. J Neurol 250:108–109PubMedGoogle Scholar
  65. 65.
    Brilla R, Nabavi DG, Schulte-Atedorneburg G et al (1999) Cerebral vasculopathy in HIV infection revealed by transcranial Doppler: a pilot study. Stroke 30:811–813PubMedGoogle Scholar
  66. 66.
    Tran Dinh YR, Mamo H, Cervoni J et al (1990) Disturbances in the cerebral perfusion of human immune deficiency virus-1 seropositive asymptomatic subjects: a quantitative tomography study of 18 cases. J Nucl Med 31:1601–1607PubMedGoogle Scholar
  67. 67.
    Tipping B, de Villiers L, Candy S, Wainwright H (2006) Stroke caused by human immunodeficiency virus-associated intracranial large-vessel aneurysmal vasculopathy. Arch Neurol 63:1640–1642PubMedGoogle Scholar
  68. 68.
    Feldman JG, Goldwasser P, Holman S et al (2003) C-reactive protein is an independent predictor of mortality in women with HIV-1 infection. J Acquir Immune Defic Syndr 32:210–214PubMedGoogle Scholar
  69. 69.
    Rhew DC, Bernal M, Aguilar D et al (2003) Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: a systematic review. Clin Infect Dis 31:959–972Google Scholar
  70. 70.
    Maggi P, Serio G, Epifani G et al (2000) Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors. AIDS 14:123–128Google Scholar
  71. 71.
    de Saint Martin L, Vandhuic O, Guillo P et al (2006) Premature atherosclerosis in HIV positive patients and cumulated time of exposure to antiretroviral therapy (SHIVA study). Atherosclerosis 185:361–367PubMedGoogle Scholar
  72. 72.
    Seminari E, Pan A, Voltini G et al (2002). Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors. Atherosclerosis 162:433–438PubMedGoogle Scholar
  73. 73.
    Mercié P, Thiébaut R, Aurillac-Lavignolle V et al (2005) Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients. HIV Med 6:380–387PubMedGoogle Scholar
  74. 74.
    Depayron M, Chessex S, Sudre P et al (2001) Premature atherosclerosis in HIV-infected individuals: focus on protease inhibitor therapy. AIDS 15:329–334Google Scholar
  75. 75.
    Jerico C, Knobel H, Calvo N et al (2006) Subclinical carotid atherosclerosis in HIV-infected patients: role of combination antiretroviral therapy. Stroke 37:812–817PubMedGoogle Scholar
  76. 76.
    Hsue PY, Lo JC, Franklin A et al (2004) Progression of atherosclerosis as assessed by carotid intimamedia thickness in patients with HIV infection. Circulation 109:1603–1609PubMedGoogle Scholar
  77. 77.
    Thiébaut R, Aurillac-Lavignolle V, Bonnet F et al (2005). Change in atherosclerosis progression in HIV infected patients: ANRS Aquitaine cohort, 1999–2004. AIDS 19:729–731PubMedGoogle Scholar
  78. 78.
    Currier JS, Kendall MA, Henry WK et al (2007) Progression of carotid intima-media thickening in HIV-infected and uninfected adults. AIDS 21:1137–1145PubMedGoogle Scholar
  79. 79.
    Hollander M, Hak AE, Koudstaal PJ et al (2003) Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke 34:2367–2372PubMedGoogle Scholar
  80. 80.
    Van Oijen M, de Jong FJ, Witteman JCM et al (2007) Atherosclerosis and risk for dementia. Ann Neurol 61:403–410PubMedGoogle Scholar
  81. 81.
    Bock AR, Schwab J, Marienhagen J et al (1994) Anticardiolipin antibodies in HIV infection: associated with cerebral perfusion defects as detected by 99mTc-HMPAO SPECT. Clin Exp Immunol 98:361–368PubMedGoogle Scholar
  82. 82.
    Brey RL, Chapman J, Levine SR et al (2003) Stroke and the antiphospholipid syndrome: consensus meeting, Taormina 2002. Lupus 12:508–513PubMedGoogle Scholar
  83. 83.
    Hassell KL, Kressin DC, Neumann A, Ellison R, Marlar RA (1994) Correlation of antiphospholipid antibodies and protein S deficiency with thrombosis in HIV-infected men. Blood Coagul Fibrinolysis 5:455–462PubMedGoogle Scholar
  84. 84.
    Mochan A, Modi M, Modi G (2005) Protein S deficiency in HIV associated ischaemic stroke: an epiphenomenon of HIV infection. J Neurol Neurosurg Psychiatry 76:1455–1456PubMedGoogle Scholar
  85. 85.
    Martin CM, Matlow AG, Chew E et al (1989) Hyperviscosity syndrome in a patient with acquired immunodeficiency syndrome. Arch Intern Med 149:1435–1436PubMedGoogle Scholar
  86. 86.
    Bruno A (2003) Cerebrovascular complications of alcohol and sympathomimetic drug abuse. Curr Neurol Neurosci Rep 3:40–45PubMedGoogle Scholar
  87. 87.
    Hanyu S, Ikeguchi K, Imai H et al (1995) Cerebral infarction associated with 3,4-methylenedioxymethamphetamine (’ecstasy’) abuse. Eur Neurol 35:173PubMedGoogle Scholar
  88. 88.
    Strobel M, Lamaury I, Brouzes F et al (1995) Accidents vasculaires cérébraux et sida. Rev Med Interne 16:743–746PubMedGoogle Scholar
  89. 89.
    Moulignier A, Baudrimont M, Martin-Negrier ML et al (1996) Fatal brain stem encephalitis due to herpes simplex virus type 1 in AIDS. J Neurol 243:491–493PubMedGoogle Scholar
  90. 90.
    Brust JC (2002) Neurologic complications of substance abuse. J Acquir Immune Defic Syndr 31(Suppl 2):S29–S34PubMedGoogle Scholar
  91. 91.
    Nolte KB, Brass LM, Fletterick CF (1996) Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology 46:1291–1296PubMedGoogle Scholar
  92. 92.
    Buttner A, Mall G, Penning R, Sachs H, Weis S (2003) The neuropathology of cocaine abuse. Leg Med 5(Suppl 1):S240–242Google Scholar
  93. 93.
    Cohen JE, Eger K, Montero A, Israel Z (1998) Rapid spontaneous resolution of acute subdural hematoma and HIV related cerebral atrophy: case report. Surg Neurol 50:241–244PubMedGoogle Scholar
  94. 94.
    Jordan BD, Navia BA, Petito C et al (1985) Neurological syndromes complicating AIDS. Front Radiat Ther Oncol 19:82–87PubMedGoogle Scholar
  95. 95.
    Meyohas MC, Roullet E, Rouzioux C et al (1989) Cerebral venous thrombosis and dual primary infection with human immunodeficiency virus and cytomegalovirus. J Neurol Neurosurg Psychiatry 52:1010–1011PubMedGoogle Scholar
  96. 96.
    Doberson MJ, Kleinschmidt-DeMasters BK (1994) Superior sagittal sinus thrombosis in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med 118:844–846PubMedGoogle Scholar
  97. 97.
    Iranzo A, Domingo P, Cadafalch J, Sambeat MA (1998) Intracranial venous and dural sinus thrombosis due to protein S deficiency in a patient with AIDS. J Neurol Neurosurg Psychiatry 64:688PubMedGoogle Scholar
  98. 98.
    Berger JR, Harris JO, Gregorios J, Norenberg M (1990) Cerebrovascular disease in AIDS: a case control study. AIDS 4:239–244PubMedGoogle Scholar
  99. 99.
    Afsari K, Frank J, Vaksman Y, Nguyen TV (2003) Intracranial venous sinus thrombosis complicating AIDS-associated nephropathy. AIDS Read 13:143–148PubMedGoogle Scholar
  100. 100.
    Spiegel M, Schmidauer C, Kampfl A, Sarcletti M, Poewe W (2001) Cerebral ergotism under treatment with ergotamine and ritonavir. Neurology 57:743–744PubMedGoogle Scholar
  101. 101.
    Martinez E, Collazos J, Mayo J (1998) Shock and cerebral infarct after rifampicin re-exposure in a patient infected with human immunodeficiency virus. Clin Infect Dis 27:1329–1330PubMedGoogle Scholar
  102. 102.
    Carvalho Felicio A, Sampaio G, Celso dos Santos WA et al (2006) Spontaneous artery dissection in a patient with human immunodeficiency virus infection. Arq Neuropsiquitr 64:306–308Google Scholar
  103. 103.
    Fénelon G, Gray F, Scaravilli F et al (1991) Ischemic myelopathy secondary to disseminated intravascular coagulation in AIDS. J Neurol 238:51–54PubMedGoogle Scholar
  104. 104.
    Gray F, Belec L, Lescs MC (1994) Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain 117:987–999PubMedGoogle Scholar
  105. 105.
    Kenyon LC, Dulaney E, Montone KT et al (1996) Varicella-zoster ventriculo-encephalitis and spinal cord infarction in a patient with AIDS. Acta Neuropathol 92:202–205PubMedGoogle Scholar
  106. 106.
    Park YD, Belman AL, Kim TS et al (1990) Stroke in pediatric acquired immunodeficiency syndrome. Ann Neurol 28:303–311PubMedGoogle Scholar
  107. 107.
    Patsalides AD, Wood LV, Atac GK et al (2002) Cerebrovascular disease in HIV-infected pediatric patients: neuroimaging findings. Am J Roentgenol 179:999–1003Google Scholar
  108. 108.
    Visudtibhan A, Visudhiphan P, Chiemchanya S (1999) Stroke and seizures as the presenting signs of pediatric HIV infection. Pediatr Neurol 20:53–56PubMedGoogle Scholar
  109. 109.
    Husson RN, Saini R, Lewis LL et al (1992) Cerebral artery aneurysms in children infected with human immunodeficiency virus. J Pediatr 121:927–930PubMedGoogle Scholar
  110. 110.
    Kure K, Llena JF, Lyman WD et al (1991) Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol 22:700–710PubMedGoogle Scholar
  111. 111.
    Lang C, Jacobi G, Kreuz W et al (1992) Rapid development of giant aneurysm at the base of the brain in an 8-year-old boy with perinatal HIV infection. Acta Histochem (Suppl) 42:83–90Google Scholar
  112. 112.
    Bonnet D, Aggoun Y, Szezepanski I et al (2004) Arterial stiffness and endothelial dysfunction in HIV-infected children. AIDS 18:1037–1041PubMedGoogle Scholar
  113. 113.
    Mazzoni P, Chiriboga CA, Millar WS, Rogers A (2000) Intracerebral aneurysms in human immunodeficiency virus infection: case report and literature review. Pediatr Neurol 23:252–255PubMedGoogle Scholar
  114. 114.
    McComsey GA, O’Riordan MA, Hazen SL et al (2007) Increased carotid intima media thickness and cardiac biomarkers in HIV infected children. AIDS 21:921–927PubMedGoogle Scholar
  115. 115.
    Vilaseca MA, Sierra C, Colome C et al (2001) Hyperhomocysteinaemia and folate deficiency in human immunodeficiency virus-infected children. Eur J Clin Invest 31:992–998PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • A. Moulignier
    • 1
  1. 1.Fondation Adolphe de RothschildService de NeurologieParisFrance

Personalised recommendations